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Abstract
Background: Iron deficiency anaemia is a common paediatric problem worldwide, with significant
neurodevelopmental morbidity if left untreated. A decrease in the mean corpuscular volume
(MCV) can be used as a surrogate marker for detecting early iron deficiency prior to definitive
investigation and treatment. An audit cycle was therefore undertaken to evaluate and improve the
identification, follow-up and treatment of abnormally low MCV results amongst the paediatric
inpatients in an English district general hospital.
Methods:  The audit cycle was performed retrospectively over two three-month periods
(February to April 2006; September to November 2006), amongst patients aged between one
month and 16 years that had full blood counts performed whilst admitted on the paediatric ward.
Patients with at least one abnormally low MCV result were identified, and their notes reviewed.
We looked for any underlying explanation for the result, adequate documentation of the result as
abnormal, and instigation of follow-up or treatment. In-between the two audit periods, the results
of the first audit period were presented to the medical staff and suggestions were made for
improvements in documentation and follow-up of abnormal results. The z-test was used to test for
equality of proportions between the two audit samples.
Results: Out of 701 inpatients across both audit periods that had full blood counts, 61 (8.7%) had
a low MCV result. Only 15% of patients in each audit period had an identifiable explanation for their
low MCV values. Amongst the remaining 85% with either potentially explicable or inexplicable
results, there was a significant increase in documentation of results as abnormal from 25% to 91%
of cases between the first and second audit periods (p = 0.00 using z-test). However, there was no
accompanying increase in the proportion of patients who received follow-up or treatment for their
abnormal results.
Conclusion: Abnormal red cell indices that may indicate iron deficiency are frequently missed
amongst paediatric inpatients. Medical staff education and the use of appropriate protocols or
pathways could further improve detection and treatment rates in this setting.
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Background
Iron-deficiency anaemia in children is an important prob-
lem worldwide, estimated to affect some 43% of the
world's children [1]. A study in the US quoted prevalence
figures for iron deficiency of 9% for toddlers aged 1–2
years, 7% for older pre-pubescent children, 9–11% for
adolescent females and 1% for adolescent males [2]. In
developed countries, poor-dietary intake of iron is the
commonest cause [3]. There is an association between
iron deficiency and a variety of aspects of neurodevelop-
ment in children; from reduced school achievement and
behavioural problems to developmental delay [4-6].
Iron-deficiency anaemia manifests itself as a microcytic,
hypochromic anaemia. Microcytosis develops either prior
to or along with any reduction in haemoglobin (Hb) lev-
els [3,7]. Hence the incidental detection of an isolated low
mean corpuscular volume (MCV) result could indicate
early iron deficiency that has not yet resulted in anaemia.
A decrease in mean corpuscular haemoglobin (MCH),
reflecting red cell hypochromia, can also be used to diag-
nose iron deficiency; however, since this decrease nor-
mally accompanies the reduction in MCV [8], it is no
more reliable a marker than the MCV for detecting iron
deficiency. With the exception of anaemia of chronic dis-
ease (ACD), other conditions that cause a microcytic,
hypochromic anaemia (e.g. thalassaemia) are much rarer
than iron deficiency, and other factors in the history and
clinical picture will usually indicate if further testing is
necessary. ACD more often causes a normocytic anaemia,
but in 30–50% of cases can cause a microcytic anaemia
[9]. In the context of a paediatric inpatient population,
ACD is likely to be a relevant factor only in those children
known to have a severe chronic illness and/or an acute,
severe illness of significant duration. The majority of pae-
diatric inpatients will have an acute, minor illness of brief
duration. Previous work has suggested that although this
type of illness can lead to a transient decrease in Hb, there
is little or no significant change in the MCV [10,11]. This
anaemia can take up to three months to resolve, depend-
ing on the level of inflammation associated with the ill-
ness [12]. There is currently no evidence that these
children would have an isolated microcytosis. The red cell
distribution width (RDW) can also help to differentiate
ACD from iron-deficiency anaemia, since this is abnor-
mally elevated in iron-deficiency anaemia, but not in
ACD [13].
The use of the MCV as a tool for guiding selection of inpa-
tients for further investigation of possible iron deficiency
has been questioned, mainly due to its moderately poor
sensitivity in detecting iron deficiency despite its apparent
high specificity [14,15]. These studies however were done
in a non-paediatric population, and used a cut-off point
of 80 fL which may not be applicable to other population
groups. One study that was performed on an outpatient
population of children aged between one and six years did
show much higher sensitivity and specificity values (both
close to 100%) for a MCV cut-off value of 75 fL when used
for detecting iron-deficiency anaemia, as opposed to iron
deficiency without anaemia [16]. One suggested reason-
ing for this phenomenon is that very early iron deficiency
develops prior to any reduction in MCV or Hb [7,8]. Occa-
sionally, pre-analytical factors can affect the accuracy of
the MCV reading by the automated red cell counter; these
include auto-reactive red blood cell antibodies leading to
red blood cell agglutination, and osmotic effects on red
blood cells in the presence of extreme hyperglycaemia
[17].
We were interested to see whether our department was
adequately detecting and following up paediatric inpa-
tients that might have iron deficiency, given the important
consequences of this condition if allowed to progress to
frank iron-deficiency anaemia. The department receives
about 3500 inpatient admissions per year from a mixed
urban and rural setting in Eastern England. Given that a
substantial proportion of these patients will have blood
tests, we decided to use the MCV as an indicator of
whether a patient might have iron deficiency. The MCV
was chosen since other tests commonly used to diagnose
iron deficiency are not routinely performed in the inpa-
tient setting at our hospital, whereas nearly every inpa-
tient who has blood taken will have a full blood count
performed and will have a MCV readily available. Further
tests (including RDW, blood films, serum ferritin levels
etc) might then be added to existing blood samples or per-
formed following recovery to further characterise whether
an iron-deficient state or alternative explanation for the
microcytosis is present.
Methods
The audit cycle was performed retrospectively on data
from two three-month periods: February to April 2006,
and September to November 2006 inclusive. Our depart-
ment had a total complement of twenty-one medical staff
at the time of the audits who were involved with inpatient
care. All clinical decisions involving the patients had
already been made prior to the commencement of data
collection for each audit period.
The first period formed the basis of our initial audit; these
findings were presented to our department's medical staff
in May 2006. This presentation also included background
information regarding iron-deficiency anaemia, the
rationale for use of the MCV as a surrogate screening
marker, and outlined a set of draft guidelines for medical
staff regarding adequate documentation and follow up of
abnormal red cell indices. These guidelines covered the
use of age-specific ranges for red cell indices to better iden-BMC Pediatrics 2009, 9:36 http://www.biomedcentral.com/1471-2431/9/36
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tify abnormal results, the adequate documentation of
abnormal results in the notes and discharge summaries,
and provided suggestions for possible follow-up tests (e.g.
addition of RDW and a blood film to previous FBC tests)
and other interventions (e.g. dietary advice) for those
patients with borderline and significantly abnormal
results. The second period formed the basis of a re-audit
to see if there was any improvement in detection and fol-
low-up rates following our presentation.
We considered all full blood count (FBC) results from the
Paediatric Admission Unit and inpatient ward at our hos-
pital (The Queen Elizabeth Hospital, King's Lynn, Nor-
folk, UK) from children aged one month to 16 years
inclusive over the time periods specified. Requests from
the Special Care Baby Unit, Outpatient Department,
Emergency Department and GPs were excluded. The age-
specific limits for Hb and MCV given by Nathan and Oski
[18] (Table 1) were used on the results to identify those
patients who had at least one FBC result with a MCV equal
to or below the lower limit for their age. For those patients
with more than one FBC result available, we used only the
result with the lowest MCV value (or Hb value if the MCVs
were equal).
We retrieved the notes of patients with a low MCV and
identified their acute diagnoses and any chronic illnesses
from detailed review of their notes. This included review-
ing the notes from the admission covered by the audit
period, as well as any other letters, discharge summaries,
previous admission records and test results that may have
been of relevance. This information was used to categorise
the low MCV result as 'explicable', potentially explicable
or 'explanation unknown'. 'Explicable' results were those
in patients who were known to be iron-deficient already,
or who had a pre-existing, long-standing chronic illness
(e.g. juvenile idiopathic arthritis) that had clearly resulted
in ACD with microcytosis. 'Potentially explicable' results
were those in patients who had a recent or ongoing acute
severe illness of significant duration, or in patients who
might have undiagnosed thalassaemia based on their eth-
nic origin. 'Explanation unknown' results were those that
could not be explained by the patient's medical history
and known risk factors for other disorders.
We then determined from the notes and discharge sum-
maries of the 'potentially explicable' and 'explanation
unknown' groups whether the laboratory abnormalities
(Hb and MCV) had been adequately documented as
abnormal, and for those that had, whether follow-up and/
or treatment was subsequently arranged for those
patients. Acceptable follow up included asking the
patient's General Practitioner via the discharge summary
to review them with regards to their low MCV and iron
status, or arranging follow-up in paediatric outpatients for
this specific purpose. Acceptable treatment included dieti-
cian advice regarding iron intake, and/or the commence-
ment of oral iron therapy.
This notes review process and categorisation of results was
performed exclusively by DNS for the first audit data, and
exclusively by SK for the second audit data; both investi-
gators used the same criteria mentioned above for result
categorisation and identification of information from the
notes.
Table 1: Normal haematological values for Haemoglobin and Mean Cell Volume in children. Adapted from [18]. Copyright Elsevier 
(2003).
Haemoglobin (g/dL) Mean Cell Volume (fL)
Age Mean Lower Limit (-2 SD) Mean Lower Limit (-2 SD)
1 month 14.0 10.0 104 85
2 months 11.5 9.0 96 77
3 to 6 months 11.5 9.5 91 74
0.5 to 2 years 12.0 10.5 78 70
2 to 6 years 12.5 11.5 81 75
6 to 12 years 13.5 11.5 86 77
12 to 18 years
Female 14.0 12.0 90 78
Male 14.5 13.0 88 78BMC Pediatrics 2009, 9:36 http://www.biomedcentral.com/1471-2431/9/36
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We used the z-test [19] to test for the equality of propor-
tions between the two audit samples. This test is based on
the assumption that the two audits are based on inde-
pendent samples, and was the most appropriate test for
our data. The STATA program (StataCorp, College Station,
TX) was used to perform our analyses.
Since this was an internal department audit which
required no extra tests or interventions to be performed
on human subjects, approval from an ethics committee
was not required. We confirmed this fact with the Norfolk
Research Ethics Committee and hospital Research Gov-
ernance Committee, prior to publication.
Results
First audit period (February – April 2006)
In the first audit period, 319 paediatric inpatients had at
least one FBC test performed. Thirty-three (10%) had a
low MCV result during their admission. The sex and age
distribution for these results is summarised in Table 2.
In term of explicability, five patients (15%) had 'explica-
ble' results; thirteen patients (39%) had 'potentially expli-
cable' results; fifteen patients (46%) had 'explanation
unknown' results. Excluding the patients with explicable
low MCV results, seven patients (25%) had their low MCV
results documented as abnormal in the notes and/or dis-
charge summary; the remaining twenty-one (75%) had
no documentation of their abnormal results and did not
receive any subsequent treatment or follow-up. Of the
seven patients whose results had been documented, four
received iron deficiency treatment and/or follow-up; the
other three received no treatment or follow-up. Overall,
only four out of thirty-three patients with a low MCV
(12%) received treatment and/or follow up.
Second audit period (September – November 2006)
In the second audit period, 382 paediatric inpatients had
at least one FBC performed. Twenty-eight (7.3%, as com-
pared to 10% from first audit, p = 0.080) had a low MCV
result during their admission. The sex and age distribution
for these results is summarised in Table 3. Two of these
patients also had a FBC result with a low MCV during the
first audit period.
The notes of one patient with a low MCV result were una-
vailable for review. Of the remaining twenty-seven
patients, four (15%; as compared to 15% from first audit,
p = 0.49) had 'explicable' results, seven (39%; as com-
pared to 26% from first audit, p = 0.14) had 'potentially
explicable' results, and sixteen (59%; as compared to 46%
from first audit, p = 0.14) had 'explanation unknown'
results. One patient each in the 'explicable' and 'poten-
tially explicable' groups also had a low MCV result in the
first audit period, and had results that were similarly cate-
gorised back then as well. Excluding the patients with
explicable low MCV results, twenty-one patients (91%; as
compared to 25% from first audit, p = 0.00) had their low
MCV results documented as abnormal in the notes and/or
discharge summary; the remaining two (8.7%) had no
documentation of their abnormal results and did not
receive any subsequent treatment or follow-up. Of the
twenty-one patients whose results had been documented,
two (9.5%; as compared to 57% from first audit, p =
0.0039) received iron-deficiency treatment and/or follow-
up; the other nineteen (90%) received no treatment or fol-
low-up. Overall, only two out of twenty-seven patients
with a low MCV (7.4%; as compared to 12% from first
audit, p = 0.27) received treatment and/or follow-up.
The overall results from both audit periods are summa-
rised in a flow chart (Figure 1). A scatter-plot of the MCV
results from both audit periods versus age, and as com-
pared against the lower MCV limit for each age group, is
also shown (Figure 2).
Discussion
Microcytosis was not an uncommon finding amongst the
paediatric inpatients who had blood tests performed;
overall, 61 out of 701 inpatients (8.7%) that had FBCs
performed across both audit periods had microcytosis. 30
of these patients (49%) had MCV values that were 2 fL or
more below the age-adjusted lower MCV limit. The pro-
portion of patients identified as having microcytosis that
Table 2: Sex and age distribution for first audit results (February 
– April 2006).
Number Proportion
Male 25 76%
Female 8 24%
<0.5 years 1 3.0%
0.5 to 2 years 1 3.0%
2 to 6 years 19 58%
6 to 12 years 9 27%
12 to 18 years 3 9.0%
Table 3: Sex and age distribution for second audit results 
(September – November 2006).
Number Proportion
Male 15 54%
Female 13 46%
<0.5 years 1 3.6%
0.5 to 2 years 4 14%
2 to 6 years 10 36%
6 to 12 years 9 32%
12 to 18 years 4 14%BMC Pediatrics 2009, 9:36 http://www.biomedcentral.com/1471-2431/9/36
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was 'explicable' remained consistent across both audits at
around 15%. Since these patients' results could be clearly
explained, they would not require any additional follow-
up or treatment, other than that already arranged for their
known illnesses.
The remaining 85% in each audit had microcytosis that
was either 'potentially explicable' or 'explanation
unknown'. Both groups of patients might have had iron
deficiency (particularly in the 'explanation unknown'
group), but diagnosis would require further dietary his-
tory from the parents and blood tests from the patients
once well in order to confirm or rule out this possibility.
Further testing might also reveal other disorders associ-
ated with microcytosis, such as thalassaemia. However,
this must be balanced against having to do a large number
of potentially unnecessary and unpleasant blood tests in
order to detect the relatively small proportion of children
that have true iron deficiency.
Our audit cycle demonstrated a significant and substantial
improvement in documentation with regards to abnor-
mal FBCs in those patients with 'potentially explicable' or
'explanation unknown' microcytosis, from 25% to 91% of
abnormal results. This could be attributed to positive
steps that were taken in our department following presen-
tation of results from the first audit, consisting of educa-
tion of other medical staff regarding the importance of
adequate documentation of abnormal FBC results in the
notes and discharge summaries.
However, the results with regard to follow-up of patients
with abnormal results were more disappointing. Despite
a far higher number of patients having their results
recorded as abnormal, only two patients (as compared
with four from the first audit) had subsequent follow-up
and/or treatment during the second audit period.
Although the educational presentation had covered fol-
low-up and treatment of low MCV results, this was clearly
Results of first audit (February – April 2006) and second audit (September – November 2006) Figure 1
Results of first audit (February – April 2006) and second audit (September – November 2006). P values are 
included where appropriate. All proportions and p values are given to 2 significant figures.
Number of patients with results 
documented as abnormal in notes
First audit: 7 (25%)
Second audit: 21 (91%)
p = 0.00*
Total number: 28 (55%)
Number of patients with 
results not documented as 
abnormal in notes
First audit: 21 (75%)
Second audit: 2 (8.7%)
Total number: 23 (45%)
Number of patients that had FBC tests
First audit: 319
Second audit: 382
Total number: 701
Number of patients with a low MCV
First audit: 33 (10%)
Second audit: 28 (7.3%)+
p = 0.080
Total number: 61 (8.7%)
Number of patients with a normal MCV
First audit: 286 (90%)
Second audit: 354 (93%)
Total number: 640 (91%)
Number of patients with 
‘explicable’ results
First audit: 5 (15%)
Second audit: 4 (15%)
p = 0.49
Total number: 9 (15%)
Number of patients with 
‘potentially explicable’ results
First audit: 13 (39%)
Second audit: 7 (26%)
p = 0.14
Total number: 20 (33%)
Number of patients with 
‘explanation unknown’ results
First audit: 15 (46%)
Second audit: 16 (59%)
p = 0.14 
Total number: 31 (52%)
Statistically significant results with p0.05 are highlighted with *.
+ One set of notes from the second audit was unavailable for review, and was excluded from subsequent analysis.
None of these patients received
treatment or follow-up
Number of patients who 
received treatment 
and/or follow-up
First audit: 4 (57%)
Second audit: 2 (9.5%)
p = 0.0039*
Total number: 6 (21%)
Number of patients 
who received no 
treatment or follow-up
First audit: 3 (43%)
Second audit: 19 (90%)
Total number: 22 (79%)BMC Pediatrics 2009, 9:36 http://www.biomedcentral.com/1471-2431/9/36
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inadequate in isolation for empowering the medical staff
to act upon the increased number of abnormal results that
would now be documented, without accompanying
printed guidelines disseminated to the ward and to all
staff. Further work would therefore be necessary to ensure
that the staff improved on following up and treating these
patients where appropriate, and that a formalised, printed
protocol or patient pathway was in place to aid this.
One suggested protocol would be to take a dietary history
and offer appropriate dietary advice to the parents of all
patients with microcytosis where there is no immediate
explanation, and to add a RDW and blood film analysis to
any FBC samples that have been taken. Patients could
then be stratified into low, moderate or high risk groups
for iron deficiency. This would then be followed by GP
follow-up with repeat FBC for the low risk patients; GP or
paediatric outpatient follow-up, testing and treatment for
the moderate risk patients; and in-hospital commence-
ment of iron treatment with paediatric follow-up and fur-
ther testing for the high risk patients. Further outpatient
testing might include repeat FBC with a blood film, iron
studies (including serum ferritin levels, transferrin levels,
transferrin saturation and iron levels), and other tests as
appropriate depending on the clinical context (e.g. hae-
moglobin electrophoresis if there is any likelihood of tha-
lassaemia).
Current practice amongst our haematology lab is to report
paediatric results as abnormal when compared against
adult ranges only. This might lead to potentially abnor-
mal results being missed by clinicians who do not then
make the effort to check the abnormal results against the
age-corrected ranges, or who are not familiar with them. A
change in haematology lab practice, whereby results from
patients under the age of 16 were reported against stand-
ardised age-specific ranges based on their date of birth,
would avoid this.
Scatter plot of MCV results versus age Figure 2
Scatter plot of MCV results versus age. The age-adjusted MCV lower limit (sourced from Table 1) is shown for compari-
son as a green line.BMC Pediatrics 2009, 9:36 http://www.biomedcentral.com/1471-2431/9/36
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For our audit, we were able to track all FBC results ordered
from our ward for the relevant time periods through the
computerised haematology results system. We are there-
fore confident that we included every paediatric inpatient
in the age range specified with a low MCV result. Informa-
tion was incomplete for only one patient from the second
audit period whose notes were unobtainable. Our results
are applicable only to hospital paediatric inpatients, and
are not representative of the incidence, treatment and fol-
low-up of microcytosis and iron deficiency in the commu-
nity setting. The age-specific MCV limits that were used
were taken from an American textbook of paediatric hae-
matology, since no age-specific limits have been formu-
lated by our local haematology laboratory for our
population. It would have been better to use local norms.
Our audit relied upon the subjective classification of ill-
nesses in order to categorise MCV results by explicability,
and hence was subject to operator bias. However, this was
minimised by only having two analysers, who both used
the same set of criteria for categorising results.
A study by Pusic et al [20] also looked at detection and fol-
low-up rates of microcytosis, in all children aged 6–36
months presenting to a Paediatric Emergency Depart-
ment. Over a four month period, 8% of children had a
low MCV with no previously identified explanation. Phy-
sicians had documented either treatment or follow-up in
only 35% of these children, and the researchers' educa-
tional interventions did not improve this detection rate.
Our findings support this study's conclusions that physi-
cians in paediatric hospital departments might be missing
important information and potential opportunities to
identify and treat iron deficiency when they consider FBC
results, and that educational interventions on their own
do not necessarily improve this.
Conclusion
Our work demonstrates that a substantial improvement in
the documentation rate or awareness of microcytosis by
clinicians (and hence potential early iron deficiency) can
be achieved through staff education. Follow-up and treat-
ment rates of these patients remained low in our audit,
but there are ways in which this could be improved, pri-
marily involving education of medical staff and the use of
a protocol or pathway. It would be interesting to see if our
experience with identification and follow-up of these
patients is similar at other hospitals in different settings.
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